Search
for
Sort by
Research 211–240 of 1000+
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
- FGF Family: From Drug Development to Clinical Application
- Dihydrotestosterone induces arterial stiffening in female mice
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Testosterone therapy for transgender men
- Ether: Fiction or Reality? A Review
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- ACNE
- TRP Channels in Skin Biology and Pathophysiology
- Forum
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- The human skin as a hormone target and an endocrine gland
- Clinical Pathobiology of Radiotherapy-Induced Alopecia: A Guide toward More Effective Prevention and Hair Follicle Repair
- Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats
- Targeting integrin pathways: mechanisms and advances in therapy
- Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal Tumors
- Diseases of the Canine Prostate Gland
- Protein Kinase C as a Therapeutic Target
- Trailing the Path to Preventive Oncology
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- Drugs and Androgenetic Alopecia: What to look out for